Umoja Biopharma’s $100 Million Series C Financing Round

Fenwick & West represented Umoja Biopharma in the transaction. Umoja Biopharma, Inc., a developer of in vivo cell therapies that aim to realize the full reach…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here